Jules A. Maltz - Mar 15, 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director, 10%+ Owner
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Mar 15, 2022
Transactions value $
$0
Form type
4
Date filed
3/17/2022, 07:15 PM
Previous filing
Dec 2, 2021
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +9.79K +106.38% 19K Mar 15, 2022 Direct F1
holding HIMS Class A Common Stock 54K Mar 15, 2022 Held by Institutional Venture Partners XV Executive Fund, L.P. F2
holding HIMS Class A Common Stock 10.1M Mar 15, 2022 Held by Institutional Venture Partners XV, L.P. F2
holding HIMS Class A Common Stock 10.2M Mar 15, 2022 Held by Institutional Venture Partners XVI, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -17 -24.64% $0.00 52 Mar 15, 2022 Class A Common Stock 17 Direct F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -871 -24.99% $0.00 2.61K Mar 15, 2022 Class A Common Stock 871 Direct F1, F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -8.91K -25% $0.00 26.7K Mar 15, 2022 Class A Common Stock 8.91K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.
F3 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.